Abbott’s UltiSynq defibrillation lead lands simultaneous US-EU approvals
The US and EU approvals for Abbott’s UltiSynq defibrillation lead were supported by results from the ASCEND CSP trial.
The post Abbott’s UltiSynq defibrillation lead lands simultaneous US-EU approvals appeared first on Medical Device Network .